Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vanderbilt Mouse Kidney Histology and Morphometry Core Resource Report Resource Website |
Vanderbilt Mouse Kidney Histology and Morphometry Core (RRID:SCR_010192) | access service resource, core facility, service resource | The overall goal of the Histology and Morphometry Core is 1) to provide a common facility and expertise for the broad spectrum of morphologic studies that may be required for interpretation of studies of various models of kidney disease and their response to interventions; 2) to provide tissue samples from existing archival specimens from various mouse and rat kidney disease models that may be used for exploration and characterization of expression patterns of various novel target molecules; and 3) to develop and enhance existing morphologic techniques to improve the ability of center investigators to localize specific molecules and tissue sections, and to interpret their significance based on the spatial localization and relationship to patterns of injury. |
is listed by: Eagle I has parent organization: Vanderbilt University; Tennessee; USA |
nlx_156671 | SCR_010192 | 2026-08-12 10:50:11 | 0 | |||||||||||
|
Baltimore Polycystic Kidney Disease (PKD) Research and Clinical Core Center Cell Culture and Engineering Resource Report Resource Website |
Baltimore Polycystic Kidney Disease (PKD) Research and Clinical Core Center Cell Culture and Engineering (RRID:SCR_015323) | access service resource, resource, core facility, service resource | Core faiclity that provides researchers with cell culturing and engineering services. | pkd, polycystic kidney disease, cell culture, cell engineering |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of Maryland School of Medicine; Maryland; USA has parent organization: Baltimore Polycystic Kidney Disease (PKD) Research and Clinical Core Center is organization facet of: Baltimore Polycystic Kidney Disease (PKD) Research and Clinical Core Center |
Polycystic Kidney Disease | NIDDK P30DK090868 | Available to the research community | SCR_015323 | 2026-08-12 10:51:08 | 0 | ||||||||
|
UAB-UCSD Core Center for Acute Kidney Injury Research Bioanalytical Core Resource Report Resource Website |
UAB-UCSD Core Center for Acute Kidney Injury Research Bioanalytical Core (RRID:SCR_015280) | access service resource, resource, core facility, service resource | Core that provides bioenergetics, oxidative stress analysis and metabolite analysis support for AKI research. It includes protocols and technology for bioanalytical analysis of oxidative stress and cellular bioenergetics as well as post-translational modifications. | bioenergetics, bioanalytical analysis, spectrometry, oxidative stress |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of Alabama at Birmingham School of Medicine; Alabama; USA has parent organization: University of California San Diego School of Medicine; California; USA has parent organization: UAB-UCSD Core Center for Acute Kidney Injury Research is organization facet of: UAB-UCSD Core Center for Acute Kidney Injury Research |
NIDDK P30DK079337 | Available to the research community | SCR_015280 | 2026-08-12 10:51:20 | 0 | |||||||||
|
UAB-UCSD Core Center for Acute Kidney Injury Research Pre-Clinical Studies of AKI Resource Report Resource Website |
UAB-UCSD Core Center for Acute Kidney Injury Research Pre-Clinical Studies of AKI (RRID:SCR_015278) | access service resource, resource, core facility, service resource | Core that provides services such as expertise in development and training in the use of rodent models of AKI, specifically in the setting of ischemia/reperfusion (I/R) injury, sepsis and renal transplantation, gamma-ray imaging (gamma camera, microSPECT/CT, microPET/CT), metabolic assessments of kidney O2 consumption, and technical expertise in isolation of primary renal and vascular cell in culture. | AKI, pre-clinical studies, murine models, imaging |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of Alabama at Birmingham School of Medicine; Alabama; USA has parent organization: University of California San Diego School of Medicine; California; USA has parent organization: UAB-UCSD Core Center for Acute Kidney Injury Research is organization facet of: UAB-UCSD Core Center for Acute Kidney Injury Research |
NIDDK P30DK079337 | Available to the research community | SCR_015278 | 2026-08-12 10:51:16 | 0 | |||||||||
|
UAB-UCSD Core Center for Acute Kidney Injury Research Administrative Core Resource Report Resource Website |
UAB-UCSD Core Center for Acute Kidney Injury Research Administrative Core (RRID:SCR_015279) | access service resource, resource, core facility, service resource | Core facility which coordinates the various activities of the center. Its various duties include facilitating interactions and collaboration among the researchers of the center, promoting scientific development through education and Pilot funding, organizing and supporting seminars, journal clubs and symposia, and maintaining communication with members. | administration, management core, administrative oversight, administrative services |
is listed by: NIDDK Information Network (dkNET) has parent organization: University of Alabama at Birmingham School of Medicine; Alabama; USA has parent organization: University of California San Diego School of Medicine; California; USA has parent organization: UAB-UCSD Core Center for Acute Kidney Injury Research is organization facet of: UAB-UCSD Core Center for Acute Kidney Injury Research |
NIDDK P30DK079337 | Available to the research community | SCR_015279 | 2026-08-12 10:51:07 | 0 | |||||||||
|
Translational Polycystic Kidney Disease (PKD) Center at Mayo Clinic Rochester Model Systems Core Resource Report Resource Website |
Translational Polycystic Kidney Disease (PKD) Center at Mayo Clinic Rochester Model Systems Core (RRID:SCR_015312) | access service resource, resource, core facility, service resource | Core that makes available PKD model systems and technologies to PKD researchers at Mayo and at other institutions. Its services include C. elegans PKD-targeted services, Zebrafish PKD-targeted services, and Rodent PKD-targeted services. | model systems, c. elegans, zebrafish, rodents, PKD genes |
is listed by: NIDDK Information Network (dkNET) has parent organization: Mayo Clinic Minnesota; Minnesota; USA has parent organization: Translational Polycystic Kidney Disease (PKD) Center at Mayo Clinic Rochester is organization facet of: Translational Polycystic Kidney Disease (PKD) Center at Mayo Clinic Rochester |
Polycystic Kidney Disease | NIDDK P30DK090728 | Available to the research community | SCR_015312 | 2026-08-12 10:51:16 | 0 | ||||||||
|
AASK Clinical Trial and Cohort Study Resource Report Resource Website |
AASK Clinical Trial and Cohort Study (RRID:SCR_006985) | AASK Cohort Study | research forum portal, portal, data or information resource, clinical trial, disease-related portal, topical portal, resource | Clinical trial investigating whether a specific class of antihypertensive drugs (beta-adrenergic blockers, calcium channel blockers, or angiotensin converting enzyme inhibitors) and/or the level of blood pressure would influence progression of hypertensive kidney disease in African Americans. The initiative consisting of 21 clinical centers and a data-coordinating center is followed by a Continuation of AASK Cohort Study to investigate the environmental, socio-economic, genetic, physiologic, and other co-morbid factors that influence progression of kidney disease in a well-characterized cohort of African Americans with hypertensive kidney disease. Only patients who were previously in the randomized trial are eligible for the cohort study. A significant discovery was made in the treatment strategy for slowing kidney disease caused by hypertension. Angiotensin-converting enzyme (ACE) inhibitors, compared with calcium channel blockers, were found to slow kidney disease progression by 36 percent, and they drastically reduced the risk of kidney failure by 48 percent in patients who had at least one gram of protein in the urine, a sign of kidney failure. ACE inhibitors have been the preferred treatment for hypertension caused by diabetes since 1994; however, calcium channel blockers have been particularly effective in controlling blood pressure in African Americans. The AASK study now recommends ACE inhibitors to protect the kidneys from the damaging effects of hypertension. The Continuation of AASK Cohort Study will be followed at the clinical centers. The patients will be provided with the usual clinical care given to all such patients at the respective centers. Baseline demographic information, selected laboratory tests, and other studies are being obtained at the initiation of the Continuation Study. The patients will be seen quarterly at the centers, and some selected studies done at these visits. Samples will be obtained and stored for additional studies and analyses at a later date. | african american, blood pressure, beta-adrenergic blocker, calcium channel blocker, angiotensin converting enzyme inhibitor, environment, socio-economic, genetic, physiology, co-morbid factor, gene, adult human, antihypertensive drug, clinical, treatment, longitudinal, demographics, laboratory test, biospecimen, biomaterial supply resource |
is listed by: One Mind Biospecimen Bank Listing is related to: NIDDK Information Network (dkNET) is related to: Chronic Renal Insufficiency Cohort Study |
End-stage renal disease, Kidney failure, Kidney disease, Hypertension, Hypertensive kidney disease | NIDDK | nlx_152750 | SCR_006985 | African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study, African American Study of Kidney Disease and Hypertension Clinical Trial and Cohort Study, Continuation of AASK Cohort Study, African American Study of Kidney Disease and Hypertension | 2026-08-12 10:49:35 | 0 | ||||||
|
Renal Disease Portal Resource Report Resource Website |
Renal Disease Portal (RRID:SCR_009030) | Renal Disease Portal | portal, data or information resource, disease-related portal, data set, topical portal | An integrated resource for information on genes, QTLs and strains associated with a variety of kidney and renal system conditions such as Renal Hypertension, Polycystic Kidney Disease and Renal Insufficiency, as well as Kidney Neoplasms. | gene, quantitative trait locus, strain, renal hypertension, kidney neoplasm, phenotype, pathway, biological process, disease, kidney, genome, gviewer, chromosome, molecular function, cellular component, visualization, synteny |
is related to: NIDDK Information Network (dkNET) is related to: Gene Ontology has parent organization: Rat Genome Database (RGD) |
Renal disease, Renal hypertension, Polycystic kidney disease, Renal insufficiency, Kidney neoplasm, Diabetes Insipidus, Hyperoxaluria, Renal hypertension, Nephritis, Nephrocalcinosis, Nephrolithiasis, Nephrosis, Renal Fibrosis, Inborn Error of Renal Tubular Transport, Uremia | nlx_153941 | SCR_009030 | RGD Renal Disease Portal | 2026-08-12 10:49:53 | 0 | |||||||
|
Thrasos Therapeutics Resource Report Resource Website |
Thrasos Therapeutics (RRID:SCR_004052) | Thrasos | commercial organization | Private, clinical stage biotherapeutics company focused on delivering new solutions to individuals affected by kidney disease. They are committed to developing novel approaches to protect, treat and restore kidney function for this patient group. Company has designed specific class of peptide compounds that have shown excellent results in controlling experimental kidney diseases, notably, models of diabetic nephropathy (kidney damage associated with diabetes), and acute kidney injury. These proprietary peptides may therefore be able to prevent and treat acute kidney injury, as well as slow and possibly reverse the progression of diabetic nephropathy. They act to control apoptosis (programmed cell death), inflammation and fibrosis (formation of scar tissue). | Controlling experimental kidney diseases, biotherapeutics, clinical, peptide, treat acute kidney injury, reverse progression diabetic nephropathy | is related to: Kidney Health Initiative | Kidney disease, Acute kidney injury, Diabetic nephropathy, Chronic kidney disease | nlx_158489 | http://www.thrasos.com/ | SCR_004052 | Thrasos Innovation Inc. | 2026-08-08 11:58:15 | 0 | ||||||
|
Pediatric Centers of Excellence in Nephrology at Cincinnati Children's Hospital Medical Center Resource Report Resource Website |
Pediatric Centers of Excellence in Nephrology at Cincinnati Children's Hospital Medical Center (RRID:SCR_015302) | portal, service resource, data or information resource, disease-related portal, topical portal, resource, access service resource | Center whose goal is to support basic, translational, and clinical research on critical pediatric kidney diseases by focusing on Acute Kidney Injury, Nephrotic Syndrome, and Lupus Nephritis. | pediatric nephrology, kidney disease |
is listed by: NIDDK Information Network (dkNET) is parent organization of: Cincinnati Children's Hospital Pediatric Center of Excellence is parent organization of: Pediatric Centers of Excellence in Nephrology at Cincinnati Children's Hospital Medical Center Gene Expression Core is parent organization of: Pediatric Centers of Excellence in Nephrology at Cincinnati Children's Hospital Medical Center Biomarker Core has organization facet: Pediatric Centers of Excellence in Nephrology at Cincinnati Children's Hospital Medical Center Gene Expression Core has organization facet: Cincinnati Children's Hospital Pediatric Center of Excellence has organization facet: Pediatric Centers of Excellence in Nephrology at Cincinnati Children's Hospital Medical Center Biomarker Core is organization facet of: Pediatric Centers of Excellence in Nephrology |
kidney disease | NIDDK P50 DK096418 | Available to the research community | SCR_015302 | 2026-08-12 10:51:16 | 0 | ||||||||
|
MediBeacon: Transdermal GFR Monitor Resource Report Resource Website 1+ mentions |
MediBeacon: Transdermal GFR Monitor (RRID:SCR_024533) | instrument resource | Transdermal Glomerular Filtration Rate monitor used to assess renal function in mouse and rat models of acute kidney injury and chronic kidney disease. | Transdermal, Glomerular Filtration Rate, monitor, assess renal function, mouse, rat, acute kidney injury, chronic kidney disease, | Vanderbilt Center for Kidney Disease ; DOD PR161028; NIDDK R01DK112688 |
PMID:30394397 | Restricted | SCR_024533 | 2026-08-08 12:02:54 | 1 | |||||||||
|
Capital Biosciences Resource Report Resource Website 1+ mentions |
Capital Biosciences (RRID:SCR_004879) | commercial organization | Biological products including Cell Immortalization Products, Clinically Defined Human Tissue, cDNA ORF Clones, Premade Adenoviruses, Purified Proteins, Viral Expression Systems and others as well as services like Custom Recombinant Adenovirus Production, Custom Recombinant Lentivirus Production, Protein Detection and Quantification and Stable Cell Line Production for academic and governmental research institutes, pharmaceutical and biotechnology industry. Capital Biosciences offers most types of human tissues, normal and diseased, with extensive clinical history and follow up information. Standard specimen format: Snap-frozen(flash-frozen), Formalin fixed and paraffin embedded (FFPE) tissues, Blood and blood products, Bone marrow, Total RNA, Genomic DNA, Total Proteins, Primary cell cultures, Viable frozen tissue. Tumor tissue samples include: Bladder cancer, Glioblastoma, Medulloblastoma, Breast Carcinoma, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Head and Neck (H&N) Carcinoma, Hepatocellular Carcinoma (HCC), Hodgkin's lymphoma, Kidney, Renal Cell Carcinoma, Lung Cancer, Non-Small Cell (NCSLC), Lung Cancer, Small Cell (SCLC), Melanoma, Mesothelioma, non-Hodgkin's Lymphoma, Ovarian Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Stomach Cancer. | cell immortalization, clinical, tissue, cdna orf clone, premade adenovirus, purified protein, viral expression, recombinant adenovirus, recombinant lentivirus, protein, detection, quantification, cell line, disease, formalin fixed and paraffin embedded, frozen, tissue, blood, blood product, bone marrow, rna, dna, protein, cell culture, tumor tissue | is listed by: One Mind Biospecimen Bank Listing | Normal, Cancer, Tumor, Bladder cancer, Glioblastoma, Medulloblastoma, Breast Carcinoma, Cervical Cancer, Colorectal Cancer, Endometrial Cancer, Esophageal Cancer, Head Carcinoma, Neck Carcinoma, Hepatocellular Carcinoma, Hodgkin's lymphoma, Kidney, Renal Cell Carcinoma, Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell, Melanoma, Mesothelioma, Non-Hodgkin's Lymphoma, Ovarian Adenocarcinoma, Pancreatic Cancer, Prostate Cancer, Stomach Cancer | nlx_85333 | http://www.capitalbiosciences.com/category/show/tissue-human-clinically-defined.html | SCR_004879 | Capital Biosciences: innovative solutions for life sciences, Capital Biosciences Inc. | 2026-08-08 11:58:28 | 2 | |||||||
|
Creative Biogene Mitochondria Related Diseases Resource Report Resource Website |
Creative Biogene Mitochondria Related Diseases (RRID:SCR_022080) | data or information resource, portal, service resource, organization portal | Creative Biogene provides comprehensive range of services and products to assist researchers in mitochondrial assays and studies. Service to validate and explore pathogenesis of mitochondria associated diseases and possible interventions. | Mitochondrial dysfunction, mitochondria associated diseases, Creative Biogene, mitochondrial assays, mitochondrial assays services | cancer, diabetes, neurodegeneration, liver diseases, cardiac, kidney, lung | Restricted | SCR_022080 | Mitochondria Related Diseases | 2026-08-12 10:52:27 | 0 | |||||||||
|
Preventing Early Renal Loss in Diabetes (PERL) Resource Report Resource Website 1+ mentions |
Preventing Early Renal Loss in Diabetes (PERL) (RRID:SCR_015862) | PERL | project portal, portal, data or information resource, disease-related portal, data set, topical portal | PERL is a clinical trial for people with type 1 diabetes who have early signs of kidney problems. Its goal is to test a new way to reduce loss of kidney function using a safe and inexpensive medicine. | kidney, type 1 diabetes, diabetes, clinical trial, medication |
is listed by: NIDDK Information Network (dkNET) is listed by: Diabetes Research Centers |
Type 1 diabetes, Diabetes, Diabetic kidney disease | NIDDK UC4 DK101108 | Available to the scientific community | SCR_015862 | Preventing Early Renal Loss in Diabetes | 2026-08-12 10:51:23 | 2 | ||||||
|
Renal Support Network Resource Report Resource Website 1+ mentions |
Renal Support Network (RRID:SCR_004049) | RSN | portal, data or information resource, disease-related portal, topical portal, patient-support portal | A nonprofit, patient-focused, patient-run organization that provides non-medical services to those affected by chronic kidney disease (CKD). RSN strives to help patients develop their personal coping skills, special talents, and employability by educating and empowering them and their family members to take control of the course and management of the disease. RSN plays a vital role in providing lawmakers and policymakers with the patient''s perspective on the needs and capabilities of people with CKD. | kidney | is related to: Kidney Health Initiative | Chronic kidney disease | nlx_158479 | SCR_004049 | 2026-08-12 10:48:55 | 1 | ||||||||
|
Frequent Hemodialysis Network Nocturnal Trial Resource Report Resource Website |
Frequent Hemodialysis Network Nocturnal Trial (RRID:SCR_007014) | FHN Nocturnal Trial | resource, clinical trial | Randomized controlled clinical trial where subjects will be randomized to conventional hemodialysis delivered three days per week home arm or to the six times per week nocturnal home hemodialysis arm which will follow any dialysis prescription provided their prescribed standardized Kt/V is at least 4.0 and treatment time is at least 6.0 hours, six times per week. Subjects were recruited from dialysis units associated with designated Clinical Centers in the U.S. and Canada and followed for 12 months. Primary Outcome Measures: * composite of 12 month mortality and the change over 12 months in left ventricular mass by cine-MRI, * a composite of 12 month mortality and the change over 12 months in the SF-36 RAND physical health composite Secondary Outcome Measures: * cardiovascular structure/funct (change in LV mass over 12 mos), health-related QoL/phys funct (change over 12 mos in PHC), * depression / dis burden (change over 12 mos in Beck Depression Inv.), nutrition (change over 12 mos in serum albumin, cognitive funct (change over 12 mos in TrailMaking Test B), mineral metabolism (change over 12 mos in aveg pre-dialysis serum phosphorus), * clin events (rate of non-access hospital or death * hypertension, anemia | hemodialysis, home, adult human, kidney, kidney disease |
is listed by: ClinicalTrials.gov is related to: Frequent Hemodialysis Network Daily Trial is related to: NIDDK Information Network (dkNET) has parent organization: NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases |
End Stage Renal Disease, Hemodialysis | NIDDK | PMID:21775973 PMID:17164834 PMID:17699439 |
nlx_152829 | SCR_007014 | Frequent Hemodialysis Network (FHN) Nocturnal Trial, Frequent Hemodialysis Network: Nocturnal Trial | 2026-08-12 10:49:36 | 0 | |||||
|
FAST BioMedical Resource Report Resource Website 1+ mentions |
FAST BioMedical (RRID:SCR_003983) | commercial organization | A clinical stage company developing a timely, precise, and convenient method for measuring plasma volume and glomerular filtration rate (GFR). They focus on development and commercialization of a patented technology for quantifying clinically relevant parameters that have been challenging or impossible to measure in the past. The company is currently developing technology for quantifying volume status and kidney function in a clinically actionable timeframe. Their technology could have a significant impact on the treatment of patients with acute kidney injury (AKI) and chronic kidney disease (CKD). | clinical, kidney function, plasma volume, glomerular filtration rate, kidney | is related to: Kidney Health Initiative | Acute kidney injury, Chronic kidney disease | grid.505053.6, nlx_158390 | https://ror.org/04rmmkk14 | SCR_003983 | 2026-08-08 11:58:14 | 3 | ||||||||
|
National Renal Administrators Association Resource Report Resource Website |
National Renal Administrators Association (RRID:SCR_003991) | NRAA | data or information resource, community building portal, portal | A nonprofit organization representing dialysis facilities and centers throughout the United States. It supports members from all types of providers including freestanding, hospital-based and national chains through the weekly e-mail newsletter, Renal Watch, the Annual Meeting, periodic workshops and other meetings. NRAA members include dialysis provider companies and management consulting companies and other companies involved in the End Stage Renal Disease (ESRD) industry and supportive of the purposes of NRAA. Individuals not directly employed or otherwise involved in companies that are NRAA members may join as individual Associate Members. The purposes for which the NRAA is organized are as follows: # To provide renal administrators the opportunity for gaining continuing education, obtaining peer recognition and expanding development in the profession. # To promote and encourage education and training for renal administrators. # To recognize individuals who have done or are doing noteworthy service in the field of renal administration. # To educate the public and members of governing bodies of health care organizations to understand the issues surrounding the practice of renal administration. # To represent the professional interests of renal administrators as a national representative spokesperson for the development and implementation of public policy. # To act as a resource on local and national ESRD issues. | kidney, dialysis | is related to: Kidney Health Initiative | Kidney disease, End Stage Renal Disease | nlx_158405 | SCR_003991 | 2026-08-12 10:48:55 | 0 | ||||||||
|
HALT PKD Resource Report Resource Website 1+ mentions |
HALT PKD (RRID:SCR_001529) | HALT PKD, HALT-PKD | resource, clinical trial | Consortium established to design and implement clinical trials of treatments that might slow the progressive loss of renal function in Polycystic Kidney Disease (PKD). Two multicenter randomized, double-blind, placebo controlled clinical trials are running concurrently to study the efficacy of renin-angiotensin-aldosterone system blockade on the progression of cystic disease (kidney volume) and on the decline in renal function in autosomal dominant polycystic kidney disease (ADPKD). Study A is to study whether intensive ACE-I/ARB blockade decrease the progression of cystic disease compared to ACE-I monotherapy patients with early disease, relatively preserved renal function, and high-normal BP or hypertension. Study B is to study whether intensive ACE-I/ARB blockade as compared to ACE-I monotherapy slow the decline in kidney function, end-stage of renal disease, or death in the setting of standard blood pressure control in hypertensive patients with moderately advanced disease. | treatment, renal function, lisinopril, placebo, telmisartan, male, female, adolescent, adult human |
is listed by: ClinicalTrials.gov is listed by: NIDDK Information Network (dkNET) is listed by: NIDDK Research Resources has parent organization: Washington University School of Medicine in St. Louis; Missouri; USA |
Polycystic kidney disease, Autosomal dominant polycystic kidney disease | NIDDK 5U01DK062408 | Free, Freely available | nlx_152832 | https://www.niddkrepository.org/studies/halt-pkd/ | http://www.pkd.wustl.edu/pkdtn/ | SCR_001529 | Polycystic Kidney Disease-Treatment Network | 2026-08-12 10:48:25 | 1 | |||
|
Indiana O'Brien Center for Advanced Microscopic Analysis Probe Delivery Core Resource Report Resource Website |
Indiana O'Brien Center for Advanced Microscopic Analysis Probe Delivery Core (RRID:SCR_015274) | access service resource, resource, core facility, service resource | Core facility which develops and characterizes methods for expressing fluorescent biosensors in the rodent kidney to be paried with intravital microscopy. | fluorescent probe, fluorescent biosensor, intravital microscopy probe, rat kidney probe |
is listed by: NIDDK Information Network (dkNET) has parent organization: Indiana University School of Medicine; Indiana; USA has parent organization: Indiana O'Brien Center for Advanced Microscopic Analysis is organization facet of: Indiana O'Brien Center for Advanced Microscopic Analysis |
NIDDK P30DK079312 | Available to the research community | SCR_015274 | 2026-08-12 10:51:20 | 0 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
